Patents by Inventor Matthew Harlin

Matthew Harlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230225962
    Abstract: The present disclosure is directed to the methods of treating a patient with schizophrenia or bipolar I disorder by administering to the patient an injectable preparation of aripiprazole, wherein the patient is administered the injectable preparation about once every two months.
    Type: Application
    Filed: March 15, 2023
    Publication date: July 20, 2023
    Inventors: Matthew Harlin, Xiaofeng WANG, Yanlin WANG, Arash RAOUFINIA
  • Publication number: 20230129919
    Abstract: The present disclosure is directed to a method of dose initiation for an aripiprazole treatment to a patient in need thereof; the patient is administered two, separate 100 to 500 mg injections of an aripiprazole intramuscular (IM) depot formulation at separate gluteal and/or deltoid injection sites, and a single dose of oral aripiprazole. The administration occurs on a first day of the treatment.
    Type: Application
    Filed: April 1, 2021
    Publication date: April 27, 2023
    Inventors: Matthew HARLIN, Xiaofeng WANG, Yanlin WANG, Arash RAOUFINIA
  • Publication number: 20220160621
    Abstract: The present disclosure is directed to the methods of treating a patient with schizophrenia or bipolar I disorder by administering to the patient an injectable preparation of aripiprazole, wherein the patient is administered the injectable preparation about once every two months.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 26, 2022
    Inventors: Matthew Harlin, Xiaofeng WANG, Yanlin WANG, Arash RAOUFINIA